hip arthroplasty News
-
Withdrawn Standard: ASTM F1612-95(2005) standard practice for cyclic fatigue testing of metallic stemmed hip arthroplasty femoral components with torsion (Withdrawn 2011)
Withdrawn Rationale: This practice covers a method for the fatigue testing of metallic stemmed femoral components used in hip arthroplasty. The described method is intended to be used for evaluation in comparisons of various designs and materials used for stemmed femoral components used in the ...
-
DePuy Synthes Acquires CUPTIMIZE™ Hip-Spine Analysis, Providing Technology to Help Surgeons Better Understand, Measure and Address Pelvic Tilt
On-site booth will host interactive experiences including product trials, hands-on demonstrations, and education Today, Johnson & Johnson MedTech* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, has acquired CUPTIMIZE™ Hip-Spine Analysis, giving surgeons an easy-to-use tool to better understand and address the impact of abnormal motion between the ...
-
New Clinical Data Supports the Use of OrthoGrid System, Inc.`s Analog and Digital Technology for Orthopedic Surgery
OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the publication of new clinical data supporting the use of its analog and digital technology in the Journal of Arthroplasty (JOA). The article, entitled “Comparison of Component Placement Accuracy Using Two Intraoperative Fluoroscopic Grid Technologies ...
-
First Successful Hip Replacement Surgeries Completed with New Libertas Taper Reduced Uncemented Fem
Norristown, PA (USA) June 25, 2020: Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company, announced today the commercial launch and first successful surgeries of its new Libertas® Taper Reduced Uncemented Femoral Stem, the latest addition to its hip system. The Libertas Taper Reduced Uncemented Femoral Stem (Libertas TR®) is a press fit, double tapered stem ...
-
Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of Postoperative Recovery Following Primary Hip or Knee Arthroplasty
Alkahest, Inc., a clinical stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced the dosing of the first patient in AKST6021-211, a phase 2 clinical trial of its proprietary human plasma fraction, GRF6021, administered before and after primary hip or knee arthroplasty, to provide key insights into the immunomodulatory effects of ...
-
OrthoGrid Announces Launch of New OrthoGrid Hip Software Application for DAA THA
OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the launch of its new OrthoGrid Hip software application after receiving FDA clearance on February 18, 2021. The new OrthoGrid Hip is the latest version of OrthoGrid System’s patented, distortion-correcting, implant-agnostic, intraoperative-alignment ...
-
2021 Utah HIP and Knee Arthroplasty Symposium
Ortho Development Corporation (ODEV) hosted the bi-annual Utah Hip and Knee Arthroplasty Symposium (UHKAS) in Park City, Utah on April 14-17, 2021. Over 120 people, including more than 60 surgeons and healthcare providers from across the country gathered for three days of interactive learning and relationship building. To kick off the event, several surgeon attendees participated in a hands-on ...
-
KiOmed Pharma reports promising long-term results in a new European multi centric survey Treatment of Advanced Knee OsteoArthritis
KiOmed Pharma, an innovative Belgian biotech company, has reported positive safety and efficacy outcomes following the treatment of nearly 80 patients suffering from Knee OsteoArthritis (OA). This European Healthcare Professional (HCP) survey yielded a global long-term improvement of OA symptoms and shows preliminary evidence of improved outcomes in patients with advanced stage OA. ‘This ...
-
Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of Evoke® Closed-Loop over Open-Loop Spinal Cord Stimulation
Saluda Medical Pty Limited (“Saluda Medical”), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced long-term results of its double-blind Level 1 EVOKE randomized controlled trial (RCT) published online in ...
-
Bonutti Orthopedic Services Joins SBL
Bonutti Orthopedic Services, Ltd., its diagnostic imaging services, Biomax Rehabilitation, its urgent care and Occupational Medicine facility have joined with Sarah Bush Lincoln, to provide more comprehensive care to the community. SBL plans to retain all of the employees in these businesses. All members of the seven-physician medical group will continue to serve the orthopedic needs of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you